U. S. Securities and Exchange Commission
                                   Washington, D. C. 20549


                                         FORM 10-QSB


[X]     QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934

        For the quarterly period ended January 31, 2003

[ ]     TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
        ACT OF 1934

         For the transition period from                to
                                        --------------    ------------------

                               Commission File No.
                               -------------------
                                     0-30499


                        CHIROPRACTIC 21 INTERNATIONAL, INC.
                        -----------------------------------
                 (Name of Small Business Issuer in its Charter)

          NEVADA                                             84-0911532
          ------                                             ----------

(State or Other Jurisdiction of                     (I.R.S. Employer I.D. No.)
 incorporation or organization)



                         4685 Highland Drive, Suite 202
                           Salt Lake City, Utah 84117
                    (Address of Principal Executive Offices)

                    Issuer's Telephone Number: (801)278-9424

                                       N/A
                                       ---
          (Former Name or Former Address, if changed since last Report)

     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Sections 13 or 15(d) of the  Securities  Exchange Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

(1)  Yes  X    No              (2)  Yes  X    No
         ----     ----                  ----         ----
<PAGE>

APPLICABLE  ONLY TO  ISSUERS  INVOLVED  IN  BANKRUPTCY  PROCEEDINGS  DURING  THE
PRECEDING FIVE YEARS

None; Not applicable

     APPLICABLE  ONLY  TO  CORPORATE  ISSUERS  Indicate  the  number  of  shares
outstanding  of each of the  Registrant's  classes  of common  stock,  as of the
latest practicable date:

                                March 10, 2003
                                    1,608,422


                       DOCUMENTS INCORPORATED BY REFERENCE

     A description of any "Documents Incorporated by Reference" is contained in
Item 6 of this Report.

PART I - FINANCIAL INFORMATION

Item 1.Financial Statements.

     The Financial  Statements of the Registrant  required to be filed with this
10-QSB  Quarterly  Report  were  prepared  by  management  and  commence  on the
following page,  together with related Notes. In the opinion of management,  the
Financial Statements fairly present the financial condition of the Registrant.

<PAGE>
<TABLE>
<CAPTION>


                       CHIROPRACTIC 21 INTERNATIONAL, INC.
                                 BALANCE SHEETS
                       January 31, 2003 and April 30, 2002

                                                            01/31/2003        04/30/2002
                                                          --------------    --------------
                                                           [Unaudited]
                                          ASSETS

<S>                                                      <C>               <C>
Assets                                                   $             0   $             0

                                                          --------------    --------------
         Total Assets                                    $             0   $             0
                                                          ==============    ==============

                          LIABILITIES AND STOCKHOLDERS' DEFICIT

Current Liabilities:
     Loans from stockholders                             $        13,068   $        10,784
     Accounts Payable                                                  0                 0
     Income Taxes Payable                                              0                 0
                                                          --------------    --------------
         Total Current Liabilities                                13,068            10,784

         Total Liabilities                                        13,068            10,784
                                                          --------------    --------------

Stockholders' Deficit:
     Common Stock, $.004 par value;
         authorized 75,000,000 shares; issued and
         outstanding, 1,608,422 shares                             6,434             5,834
     Paid-in Capital                                             959,282           959,282
     Deficit accumulated prior to the development stage         (938,764)         (938,764)
     Deficit accumulated during the development stage            (40,020)          (37,136)
                                                          --------------    --------------
         Total Stockholders' Deficit                             (13,068)          (10,784)

                                                          --------------    --------------
         Total Liabilities and Stockholders' Deficit     $             0   $             0
                                                          ==============    ==============

</TABLE>
<PAGE>
<TABLE>
<CAPTION>

                       CHIROPRACTIC 21 INTERNATIONAL, INC.
                            STATEMENTS OF OPERATIONS
   For the Three Month and Nine Month Periods Ended January 31, 2003, 2002 and
  for the Period from Reactivation [December 15, 1998] through January 31, 2003

                                          Three       Three         Nine       Nine         From the
                                          Months      Months       Months     Months      Beginning of
                                          Ended       Ended        Ended      Ended       Reactivation
                                                                                            through
                                        01/31/2003  01/31/2002  01/31/2003  01/31/2002     01/31/2003
                                        ----------  ----------  ----------  ----------  ----------------
                                        [Unaudited] [Unaudited] [Unaudited] [Unaudited]   [Unaudited]
REVENUE
<S>                                    <C>         <C>         <C>         <C>         <C>
       Income                          $         0 $         0 $         0 $         0 $               0
                                        ----------  ----------  ----------  ----------  ----------------
NET REVENUE                                      0           0           0           0                 0

Operating Expenses
       General and Administrative     $        479 $       403 $     2,884 $     2,297 $          40,020
       Expenses
                                        ----------  ----------  ----------  ----------  ----------------
Total Operating Expenses                       479         403       2,884       2,297            40,020


                                        ----------  ----------  ----------  ----------  ----------------
Net Income Before Taxes               $       (479)$      (403)$    (2,884)$    (2,297)$         (40,020)
                                         ==========  ==========  ==========  ==========  ================

Income/Franchise taxes                           0           0           0           0                 0

Net loss                                      (479)       (403)     (2,884)     (2,297)          (40,020)

Loss Per Share                        $      (0.01)$     (0.01)$     (0.01)$     (0.03)$           (0.01)
                                        ==========  ==========  ==========  ==========  ================

Weighted Average Shares Outstanding      1,608,422   1,458,422   1,555,422   1,458,224         1,555,422
                                        ==========  ==========  ==========  ==========  ================


</TABLE>
<PAGE>
<TABLE>
<CAPTION>

                       CHIROPRACTIC 21 INTERNATIONAL, INC.
                            STATEMENTS OF CASH FLOWS
   For the Three Month and Nine Month Periods Ended January 31, 2003, 2002 and
  for the Period from Reactivation [December 15, 1998] through January 31, 2003

                                       Three        Three       Nine        Nine        From the
                                       Months       Months      Months      Months     Beginning of
                                       Ended        Ended       Ended       Ended    Reactivation
                                                                                        through
                                     01/31/2003   01/31/2002  01/31/2003  01/31/2002   01/31/2003
                                     ----------   ----------  ----------  ---------  ---------------
                                      [Unaudited] [Unaudited] [Unaudited] [Unaudited]  [Unaudited]

Cash Flows Used For Operating Activities
-----------------------------------------------
<S>                                  <C>          <C>         <C>         <C>       <C>
  Net Loss                           $     (479)  $     (403) $   (2,884) $  (2,297)$        (40,020)
  Adjustments to reconcile net loss to net cash
    used in operating activities:
    Issued stock for forgiveness of debt      0            0         600          0           26 400
    Increase/(Decrease) in loans from       479          403       2,284      2,297           13,620
shareholder
                                     ----------   ----------  ----------  ---------  ---------------
      Net Cash Used For Operating             0            0           0          0                0
Activities
                                     ==========   ==========  ==========  =========  ===============

Cash Flows Provided by Financing              0            0           0          0                0
Activities
-------------------------------------

      Net Increase In Cash                    0            0           0          0                0

      Beginning Cash Balance                  0            0           0          0                0

      Ending Cash Balance          $          0$           0$          0$         0$               0
                                     ----------   ----------  ----------  ---------  ---------------
</TABLE>
<PAGE>
NOTES  TO  FINANCIAL   STATEMENTS:

NOTE 1 -   INTERIM FINANCIALS

          Interim financial statements reflect all adjustments which are, in the
          opinion of  management,  necessary to a fair  statement of the results
          for the periods.  The April 31, 2002  balance   sheet has been derived
          from  the  audited  financial  statements.   These  interim  financial
          statements   conform  with  the  requirements  for  interim  financial
          statements  and  consequently  do  not  include  all  the  disclosures
          normally required by generally accepted accounting principles.

NOTE 2 -   GOING CONCERN

          The  Company's  financial  statements  are  prepared  using  generally
          accepted  accounting  principles  applicable  to a going concern which
          contemplates  the realization of assets and liquidation of liabilities
          in the normal course of business.  However,  the Company does not have
          significant  cash  or  other  material  assets,  nor  does  it have an
          established source of revenues sufficient to cover its operating costs
          and to allow it to  continue as a going  concern.  It is the intent of
          the Company to seek a merger with an existing,  operating company.  In
          the interim, shareholders of the Company have committed to meeting its
          minimal operating expenses.
<PAGE>

Item 2.Management's Discussion and Analysis or Plan of Operation.

Plan of Operation.

     The Company has not engaged in any material operations in the period ending
January 31, 2003, the Company has had no material  business  operations for over
ten years.  The  Company  intends to  continue  to seek out the  acquisition  of
assets,  property  or  business  that may be  beneficial  to the Company and its
stockholders.

     The Company's only foreseeable cash requirements  during the next 12 months
will relate to maintaining  the Company in good standing in the State of Nevada,
keeping its reports "current" with the Securities and Exchange Commission or the
payment of expenses  associated  with reviewing or  investigating  any potential
business  venture.  Management does not anticipate that the Company will have to
raise additional funds during the next 12 months,  however, if additional moneys
are needed,  they may be advanced by  management  or principal  stockholders  as
loans to the Company. Because the Company has not identified any such venture as
of the date of this Report,  it is  impossible  to predict the amont of any such
loan.  However,  any such loan will not exceed  $25,000  and will be on terms no
less favorable to the Company than would be available  from a commercial  lender
in an arm's length  transaction.  As of the date of this Report, the Company has
not begun seeking any acquisition.

Results of Operations.

     The Company has had no operations during the quarterly period ended January
31, 2003, or since on or before  approximately 1989. During the quarterly period
covered by this Report, the Company received no revenue and incurred expenses of
$479, stemming from general and administrative expenses.

Liquidity

     At January 31, 2003,  the Company had total current  assets of $0 and total
liabilities of $13,068.

Item 3.   Controls and Procedures.

     An  evaluation   was  performed   under  the   supervision   and  with  the
participation of the Company's management,  including the CEO and CFO, regarding
the  effectiveness  of the  design and  operation  of the  Company's  disclosure
controls and procedures  within 90 days before the filing date of this quarterly
report. Based on that evaluation,  the Company's  management,  including the CEO
and CFO,  concluded that the Company's  disclosure  controls and procedures were
effective.  There have been no  significant  changes in the  Company's  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to their evaluation.


PART II - OTHER INFORMATION

Item 1.Legal Proceedings.

None; not applicable.

Item 2.Changes in Securities.

None; not applicable

Item 3.Defaults Upon Senior  Securities.

None; not applicable.

Item 4.Submission of Matters to a Vote of Security Holders.

None; not applicable

Item 5.Other Information.

None; applicable

Item 6.Exhibits and Reports on Form 8-K.

None; not applicable

(b)Reports on Form 8-K.

None; Not Applicable.


<PAGE>

SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                 CHIROPRACTIC 21 INTERNATIONAL, INC.



                                By/S/ Kirsten Lovato
Date:  3-12-03                  Kirsten Lovato, President and Director


Date:  3-12-03                  By/S/ Vickie Jenson
                                Vickie Jenson, Secretary and Director

<PAGE>

                           CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, Kirsten Lovato, President and Director of Chiropractic 21 International,
Inc., certify that:

     1. I have reviewed this Quarterly  Report on Form 10-QSB of Chiropractic 21
International, Inc.;

     2. Based on my knowledge, this Quarterly Report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this Quarterly
Report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this Quarterly  Report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
Registrant as of, and for, the periods presented in this Quarterly Report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Registrant and we have:

          a) designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the Registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  Quarterly  Report is being
     prepared;

          b) evaluated the effectiveness of the Registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     Quarterly Report (the "Evaluation Date"); and

          c)  presented  in this  Quarterly  Report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The Registrant's other certifying officer and I have disclosed, based on
our most recent evaluation, to the Registrant's auditors and the audit committee
of  Registrant's  board of  directors  (or  persons  performing  the  equivalent
function);

          a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the  Registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     Registrant's auditors any material weaknesses in internal controls; and

          b) any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  Registrant's  internal
     controls; and

     6. The Registrant's  other certifying  officer and I have indicated in this
Quarterly  Report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.

Dated:  3-12-03                      Signature:By/S/ Kirsten Lovato
                                               ---------------------------
                                               Kirsten Lovato
                                               President and Director
<PAGE>
                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

     I, Vickie  Jenson,  Secretary,  Treasurer and Director of  Chiropractic  21
International, Inc., certify that:

     1. I have reviewed this Quarterly  Report on Form 10-QSB of Chiropractic 21
International, Inc.;

     2. Based on my knowledge, this Quarterly Report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this Quarterly
Report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information  included in this Quarterly  Report,  fairly present in all material
respects the financial  condition,  results of operations  and cash flows of the
Registrant as of, and for, the periods presented in this Quarterly Report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Registrant and we have:

          a) designed  such  disclosure  controls and  procedures to ensure that
     material information relating to the Registrant, including its consolidated
     subsidiaries,  is  made  known  to  us by  others  within  those  entities,
     particularly  during  the period in which  this  Quarterly  Report is being
     prepared;

          b) evaluated the effectiveness of the Registrant's disclosure controls
     and procedures as of a date within 90 days prior to the filing date of this
     Quarterly Report (the "Evaluation Date"); and

          c)  presented  in this  Quarterly  Report  our  conclusions  about the
     effectiveness  of the  disclosure  controls  and  procedures  based  on our
     evaluation as of the Evaluation Date;

     5. The Registrant's other certifying officer and I have disclosed, based on
our most recent evaluation, to the Registrant's auditors and the audit committee
of  Registrant's  board of  directors  (or  persons  performing  the  equivalent
function);

          a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the  Registrant's  ability to record,
     process,  summarize and report  financial data and have  identified for the
     Registrant's auditors any material weaknesses in internal controls; and

          b) any fraud,  whether or not material,  that  involves  management or
     other employees who have a significant  role in the  Registrant's  internal
     controls; and

     6. The Registrant's  other certifying  officer and I have indicated in this
Quarterly  Report  whether or not there  were  significant  changes in  internal
controls or in other factors that could  significantly  affect internal controls
subsequent to the date of our most recent  evaluation,  including any corrective
actions with regard to significant deficiencies and material weaknesses.



Dated:  3-12-03                      Signature:  By/S/ Vickie Jenson
                                               ---------------------
                                               Vickie Jenson
                                               Secretary, Treasurer and Director
<PAGE>

                            CERTIFICATION PURSUANT TO
                              18 U.S.C.SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly  Report of Chiropractic 21  International,
Inc. (the  "Company") on Form 10-QSB for the period ending  January 31, 2003, as
filed with the  Securities  and  Exchange  Commission  on the date  hereof  (the
"Report"),  we,  Kirsten  Lovato,  President  and  Director  and Vickie  Jenson,
Secretary, Treasurer and Director of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that to the best of our knowledge and belief:

     (1) The Report fully  complies  with the  requirements  of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.

     Dated: 3-12-03                        By/S/ Kirsten Lovato
           --------------                  -----------------------------
                                           Kirsten Lovato
                                           President and Director


     Dated: 3-12-03                        B/S/ Vickie Jenson
           --------------                  -----------------------------
                                           Vickie Jenson
                                           Secretary, Treasurer and Director